美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Metsera Inc.

39.43

-1.0400-2.57%

盘前：37.75-1.6800-4.26%07:20 EDT

成交量：150.98万

成交额：6,031.03万

市值：41.42亿

市盈率：-4.39

高：40.82

开：39.01

低：37.00

收：40.47

数据加载中...

总览公司新闻公告

Metsera季度亏损超预期，股价暴跌

2025年美股IPO前十大精选

BUZZ-富国银行以 "增持 "评级启动对 Metsera 的研究

Guggenheim：维持Metsera评级，由买入调整至买入评级, 目标价由56.00美元调整至62.00美元。

更正-实验性减肥药在小型早期试验中显示出前景，美塞拉公司业绩上升

BUZZ-美特斯邦威因减肥药的早期研究成果而获益

Metsera, Inc.2025财年第一财季实现净利润-76.59百万美元，同比减少285.26%

Nucana Plc盘中异动急速上涨5.31%

Metsera, Inc.2024财年实现净利润-2.09亿美元，同比减少342.70%

嗡嗡声--美国股票走势-Maze Therapeutics、UFP Technologies、Itron

嗡嗡声--美国股票走势-礼来、Krispy Kreme、贝宝

Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。

嗡嗡声--美国股票走势-Zoom Communications、Home Depot、Civitas Resources

BUZZ-美银美林以 "买入 "评级开始覆盖减肥药开发商 Metsera

热闹的“2025减肥药第一股”，不属于我们

异动解读 | Metsera在纳斯达克成功上市筹资2.75亿美元股价盘中大涨41.67%

医疗IPO活跃，今晚Metsera和Maze上市

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/MTSR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":39.43,"timestamp":1753732800000,"preClose":40.47,"halted":0,"volume":1509833,"hourTrading":{"tag":"盘前","latestPrice":37.75,"preClose":39.43,"latestTime":"07:20 EDT","volume":208,"amount":7878.610272000001,"timestamp":1753788003451},"delay":0,"floatShares":64513712,"shares":105055538,"eps":-8.989882,"marketStatus":"盘前交易","change":-1.04,"latestTime":"07-29 07:25:17 EDT","open":39.01,"high":40.82,"low":37,"amount":60310347.127485,"amplitude":0.094391,"askPrice":38.1,"askSize":100,"bidPrice":37.28,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-8.989882,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753795800000},"marketStatusCode":1,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":39.43,"preHourTrading":{"tag":"盘前","latestPrice":37.75,"preClose":39.43,"latestTime":"07:20 EDT","volume":208,"amount":7878.610272000001,"timestamp":1753788003451},"postHourTrading":{"tag":"盘后","latestPrice":36.48,"preClose":39.43,"latestTime":"19:45 EDT","volume":34917,"amount":1272882.2876,"timestamp":1753746325756},"volumeRatio":1.6606846080576643,"impliedVol":1.5133,"impliedVolPercentile":0.8222},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-27.09%","roe":"-108.40%","lyrEps":-14.490661,"volumeRatio":1.6606846080576643,"shares":105055538,"dividePrice":0,"high":40.82,"amplitude":0.094391,"preClose":40.47,"low":37,"week52Low":12.3,"pbRate":"8.20","week52High":47.4,"institutionHeld":0,"latestPrice":39.43,"committee":-0.834862,"eps":-8.989882,"divideRate":0,"volume":1509833,"delay":0,"ttmEps":-8.989882,"open":39.01,"prevYearClose":18,"prevWeekClose":40.47,"prevMonthClose":28.45,"prevQuarterClose":28.45,"fiveDayClose":39.91,"twentyDayClose":28.59,"sixtyDayClose":24.11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555576702","title":"Metsera季度亏损超预期，股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2555576702","media":"英为财情","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555576702?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 04:55","pubTimestamp":1753736100,"startTime":"0","endTime":"0","summary":"Investing.com -- 专注于肥胖和代谢疾病的临床阶段生物制药公司Metsera, Inc. 周一报告的第二季度亏损超出预期，导致其股价下跌8.7%，投资者对这一业绩不佳反应消极。Metsera首席执行官Whit Bernard表示：\"2025年第二季度，我们在超长效、可组合的注射剂和营养刺激型口服激素类似物领先产品线上取得了快速进展。Metsera还提前完成了VESPER-2和VESPER-3研究的招募工作。截至2025年6月30日，Metsera保持了5.309亿美元的强劲现金状况，高于2024年底的3.524亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/earnings/article-93CH-2906176","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Metsera季度亏损超预期，股价暴跌","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2548233045","title":"2025年美股IPO前十大精选","url":"https://stock-news.laohu8.com/highlight/detail?id=2548233045","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548233045?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 10:43","pubTimestamp":1751596992,"startTime":"0","endTime":"0","summary":"2025年美股IPO市场在经历了2022–2023年的冷清后，显著回暖。以下我们梳理出今年以来股价表现最亮眼的十大IPO企业，并结合其业务结构、融资规模和上涨逻辑进行简要分析。下面是在2025年IPO，股价至今回报率最高的前10支股票：1. Circle Internet Group今年最具话题性的IPO案例。募资规模约720万美元。展望下半年，IPO节奏预计仍将延续，建议投资者密切关注AI芯片基础设施、医疗设备国产替代、电动航空及金融科技等细分赛道的下一批潜力新股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/07/04104351476943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["JEM","SDM","AIRO","BK4187","BK4023","LZMH","BK4127","BK4009","SKBL","WTF","BK4129","CRCL","BK4159","MTSR","MNTN","BK4139","FATN"],"gpt_icon":1},{"id":"2544122957","title":"BUZZ-富国银行以 \"增持 \"评级启动对 Metsera 的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2544122957","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544122957?lang=zh_cn&edition=fundamental","pubTime":"2025-06-20 20:21","pubTimestamp":1750422066,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nL4T3SN0QR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR"],"gpt_icon":0},{"id":"2542634533","title":"Guggenheim：维持Metsera评级，由买入调整至买入评级, 目标价由56.00美元调整至62.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542634533","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542634533?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 22:52","pubTimestamp":1749567176,"startTime":"0","endTime":"0","summary":"Guggenheim：维持Metsera(MTSR.US)评级，由买入调整至买入评级, 目标价由56.00美元调整至62.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102258149516716a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102258149516716a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTSR"],"gpt_icon":0},{"id":"2542533643","title":"更正-实验性减肥药在小型早期试验中显示出前景，美塞拉公司业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2542533643","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542533643?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 00:02","pubTimestamp":1749484934,"startTime":"0","endTime":"0","summary":"更正-实验性减肥药在小型早期试验中显示出前景，美塞拉公司业绩上升第3段更正为36天，而不是36周路透6月10日 - 减肥药开发商Metsera MTSR.O的股价周一上涨了25%，因为该公司的实验性药物在一项小型早期试验中帮助患者减轻了体重，显示出每月给药的潜力。Metsera 的股价在早盘交易中触及 35.19 美元，午盘时上涨了 5%。美塞拉公司对 80 名患者进行的研究数据显示，其药物的半衰期约为 19 天，支持每月服药一次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nL4T3SC15E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1261432733.SGD","LU0471298694.HKD","BK4588","LU0575583348.USD","LU1051770623.HKD","LU0354030511.USD","LU1430594728.SGD","LU1732799900.SGD","LU2264538146.SGD","LU0672654240.SGD","LU1003077747.HKD","LU2089984988.USD","LU1868836914.USD","LU0499090636.EUR","LU0882574139.USD","LU0965509283.SGD","IE0002141913.USD","LU1720051017.SGD","MTSR","LU0738911758.USD","LU2091194634.USD","LU0114720955.EUR","BK4599","LU0823416689.USD","LU0943347566.SGD","LU0963555726.SGD","LU1487256676.USD","LU1037948541.HKD","03165","ABBV","LU0784384876.USD","LU2471134796.USD","LU0820561909.HKD","IE00BGHQF631.EUR","IE00BVYPNW00.USD","LU1064131342.USD","LU2491050154.USD","LU1929549753.HKD","BK4581","AZN.UK","LU0109394709.USD","LU1064927863.SGD","LU0097036916.USD","LU0266013472.USD","LU0795875169.SGD","LU0310800965.SGD","LU0128525689.USD","LU0545039389.USD","IE00BFTCPJ56.SGD"],"gpt_icon":1},{"id":"2542106382","title":"BUZZ-美特斯邦威因减肥药的早期研究成果而获益","url":"https://stock-news.laohu8.com/highlight/detail?id=2542106382","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542106382?lang=zh_cn&edition=fundamental","pubTime":"2025-06-09 20:55","pubTimestamp":1749473727,"startTime":"0","endTime":"0","summary":"6月9日 -  ** 药物开发商Metsera MTSR.O股价盘前上涨17.28%至32.24美元 ** 该公司称 ，其试验性减肥药MET-233i在36天的小型早期试验中，经安慰剂调整后体重减轻了8.4%。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nL4S3SC0XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2536591077","title":"Metsera, Inc.2025财年第一财季实现净利润-76.59百万美元，同比减少285.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536591077","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536591077?lang=zh_cn&edition=fundamental","pubTime":"2025-05-19 00:00","pubTimestamp":1747584038,"startTime":"0","endTime":"0","summary":"5月19日，Metsera, Inc.公布财报，公告显示公司2025财年第一财季净利润为-76.59百万美元，同比减少285.26%；其中营业收入为0.00美元，每股基本收益为-0.73美元。从资产负债表来看，Metsera, Inc.总负债1.85亿美元，其中短期债务9.54百万美元，资产负债比为3.74，流动比率为0.07。机构评级：截至2025年5月19日，当前有2家机构对Metsera, Inc.目标价做出预测，其中目标均价为47.00美元，其中最低目标价为38.00美元，最高目标价为56.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000142a6e3a71d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000142a6e3a71d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTSR"],"gpt_icon":0},{"id":"2527160001","title":"Nucana Plc盘中异动 急速上涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527160001","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527160001?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 22:13","pubTimestamp":1744640000,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时13分，Nucana Plc股票出现波动，股价快速拉升5.31%。Nucana Plc股票所在的生物技术行业中，整体涨幅为1.35%。Nucana Plc公司简介：NuCana PLC是一家生物制药公司，专注于通过 ProTide 技术改善癌症患者的治疗结果。该公司利用专有的 ProTide 技术开发新药，旨在克服关键的抗癌机制，并在癌细胞中产生更高浓度的抗癌代谢物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221321aa2c6e80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414221321aa2c6e80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MTSR","NCNA"],"gpt_icon":0},{"id":"2522519620","title":"Metsera, Inc.2024财年实现净利润-2.09亿美元，同比减少342.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522519620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522519620?lang=zh_cn&edition=fundamental","pubTime":"2025-03-28 15:00","pubTimestamp":1743145230,"startTime":"0","endTime":"0","summary":"3月28日，Metsera, Inc.公布财报，公告显示公司2024财年净利润为-2.09亿美元，同比减少342.70%；其中营业收入为0.00美元，每股基本收益为-14.49美元。从资产负债表来看，Metsera, Inc.总负债1.64亿美元，其中短期债务9.49百万美元，资产负债比为2.82，流动比率为0.06。机构评级：截至2025年3月28日，当前有2家机构对Metsera, Inc.目标价做出预测，其中目标均价为47.00美元，其中最低目标价为38.00美元，最高目标价为56.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328150032a6a70ec9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250328150032a6a70ec9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MTSR"],"gpt_icon":0},{"id":"2514904306","title":"嗡嗡声--美国股票走势-Maze Therapeutics、UFP Technologies、Itron","url":"https://stock-news.laohu8.com/highlight/detail?id=2514904306","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514904306?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 03:44","pubTimestamp":1740512663,"startTime":"0","endTime":"0","summary":".N美国东部时间13:30，道琼斯工业平均指数.DJI上涨0.11%，报43,508.59点。标准普尔500指数.SPX下跌0.55%，报5950.58点；纳斯达克综合指数.IXIC下跌1.25%，报19045.13点。标准普尔 500 指数.PG.INX涨幅前三名是： ** Solventum Corp SOLV.N，上涨 10.4. ** Concord Medical Services Holdings Ltd CCM.N，上涨 15.7. 纳斯达克.PL.O百分比跌幅前三名： ** Transcode Therapeutics Inc RNAZ.OQ，下跌 42.5. ** Connexa Sports Technologies Inc YYAI.OQ，跌幅 40.9** Li Auto Inc LI.O，下跌 40.9%：。BUZZ - 美国银行开始对减肥药开发商Metsera进行评级，给予 \"买入 \"评级  nL3N3PG101. BUZZ - 美国银行开始对胰岛素设备制造商 Beta Bionics 进行 \"买入 \"评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3S3PG1YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSCO","DOMH","NVD3.UK","CAKE","NVIW.SI","ITRI","MAZE","TNDM","NVDY","BGC","NVDU","LVTX","MTSR","EVER","NTRA","NVDD","STRK","NVDS.UK","TSYW.SI","DNUT","HRMY","IART","GSHD","ADIL","BBIO","BBNX","NVD2.UK","AXGN","AHCO","ONVO","HSIC","PTLO","SNVD.UK","PODD","RETO","2NVD.UK","KDP","UFPT","NVDX"],"gpt_icon":1},{"id":"2514156097","title":"嗡嗡声--美国股票走势-礼来、Krispy Kreme、贝宝","url":"https://stock-news.laohu8.com/highlight/detail?id=2514156097","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514156097?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493809,"startTime":"0","endTime":"0","summary":"nL3N3PG0XA ** JOYY Inc YY.O:BUZZ - 因百度收购该公司直播业务交易而上涨   nL3N3PG0YU ** Hims & Hers Health Inc HIMS.N:BUZZ - 因警告可能停止复方制剂Wegovy而下滑。nL3N3PG0XL ** Amer Sports Inc AS.N:BUZZ - 因年度预测大幅低于预期而下滑   nL3N3PG0ZA ** Unity Software U.N：BUZZ - 在6亿美元可转换交易定价后下滑  nL6N3PG0HC ** Civitas Resources Inc CIVI.N:BUZZ - 因第四季度利润不及预期而下跌    nL3N3PG10V ** Metsera Inc MTSR.O:BUZZ - 美国银行以 \"买入 \"评级开始覆盖减肥药开发商Metsera。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG1DP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02020","MTSR","IART","AS","DNUT","YY","AU","KDP","NVIW.SI","ONVO","82020","CAKE","NIO.SI","NVDS","LLY","PTLO","CIVI","NTRA","HD","BBNX","CLF","NEM","SRE","CSCO","EVER","DOMH","HRMY","BKSY","ZM","CHGG","SNVD.UK","89888","PLNT","PYPL"],"gpt_icon":1},{"id":"2514097940","title":"Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097940","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514097940?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"Metsera(MTSR.US)获坎托菲茨杰拉德公司首次覆盖，给予增持评级。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MTSR"],"gpt_icon":0},{"id":"2514209339","title":"嗡嗡声--美国股票走势-Zoom Communications、Home Depot、Civitas Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2514209339","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514209339?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 20:10","pubTimestamp":1740485430,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG128:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVS.SI","LU0640476718.USD","LU0127658192.USD","AS","89888","2NVD.UK","ANPDY","82020","NVD2.UK","YY","CIVI","IE00B19Z9505.USD","HD","LU1162221912.USD","NIO.SI","NVDS","LU0456827905.SGD","LU0494093205.USD","NVD","SNVD.UK","3NVD.UK","EVER","NVIW.SI","NVD3.UK","02020","NVDY","NVDU","NVDS.UK","DOMH","LU1718418525.SGD","ZM","LU1242518931.SGD","NVDX","MTSR","NVDD"],"gpt_icon":1},{"id":"2514060714","title":"BUZZ-美银美林以 \"买入 \"评级开始覆盖减肥药开发商 Metsera","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060714","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060714?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:49","pubTimestamp":1740484170,"startTime":"0","endTime":"0","summary":"BUZZ-美银美林以 \"买入 \"评级开始覆盖减肥药开发商 Metsera2月25日 -  ** 博雅全球研究公司开始对减肥药开发商Metsera MTSR.O进行评级，给予 \"买入 \"评级，目标价为38美元。** MTSR 的口服肽 MET-224o 的 \"生物利用率 \"可能比目前获批的口服肽诺和诺德的NOVOb.CO Rybelsus 高 5-6 倍。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3T3PG10N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAC","MTSR"],"gpt_icon":0},{"id":"2511567929","title":"热闹的“2025减肥药第一股”，不属于我们","url":"https://stock-news.laohu8.com/highlight/detail?id=2511567929","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511567929?lang=zh_cn&edition=fundamental","pubTime":"2025-02-13 13:54","pubTimestamp":1739426077,"startTime":"0","endTime":"0","summary":"2025年，美股第一家上市的减肥药biotech涨疯了。1月31日，Metsera上市首日，股价涨幅达到47.22%。在接下来的7个交易日里，股价继续上涨，最新市值已经突破30亿美元。而这一切，距离Metsera创立的2022年，不过3年时间。对于国内外众多押注GLP-1的biotech来说，这无疑也是他们梦寐以求的。公司的定位是“彻底改变肥胖治疗”，其核心布局分为两大类。所以，Metsera认为，MET-097i的给药周期，能延长至1个月1次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/250698","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","BK1574","MTSR","BK1161","BK4139","BK1191","01477"],"gpt_icon":0},{"id":"1191771744","title":"异动解读 | Metsera在纳斯达克成功上市 筹资2.75亿美元 股价盘中大涨41.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191771744","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191771744?lang=zh_cn&edition=fundamental","pubTime":"2025-02-01 01:36","pubTimestamp":1738344987,"startTime":"0","endTime":"0","summary":"在医疗行业IPO活跃的大环境下,Metsera Inc. 于今日在美国纳斯达克成功上市,公司股价盘中大涨41.67%,引起了市场广泛关注。据报道,Metsera是一家临床阶段的生物技术公司,正在开发基于GLP-1机制和其他生物靶点的注射和口服药物来治疗肥胖症及相关疾病。在此次IPO中,公司以每股18美元的发行价共发行了1528万股,募资总额高达2.75亿美元。以发行价计算,Metsera的估值约为18.5亿美元。IPO后,这些机构将继续持有Metsera股权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Metsera在纳斯达克成功上市 筹资2.75亿美元 股价盘中大涨41.67%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MTSR"],"gpt_icon":0},{"id":"2507331069","title":"医疗IPO活跃，今晚Metsera和Maze上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2507331069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507331069?lang=zh_cn&edition=fundamental","pubTime":"2025-01-31 15:40","pubTimestamp":1738309211,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Metsera和Maze Therapeutics这两家制药商在周四公布了首次公开募股定价。根据一份声明，Metsera IPO定价为每股18美元，该公司将出售1530万股股票以筹资2.75亿美元。资料显示，Metsera是一家位于临床阶段的生物技术公司，开发治疗肥胖及相关疾病的注射和口服药物。该公司的最大股东是Third Rock Ventures的子公司，其他投资者包括ARCH Venture Partners的子公司等。在这个1月，Beta Bionics周三进行了2.04亿美元的IPO，亚盛医药于1月23日发行了1.26亿美元的美国存托股票。","market":"sh","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1245141.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","MTSR","MAZE"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1750651200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-07-28","current":-15.99337,"percent":0.282051,"low":-55.8522,"twenty":-17.210578,"median":-12.027829,"eighty":-10.630252,"high":-6.570442,"avg":-13.775215,"sd":5.137094,"marketCap":4251597622},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-07-28","current":-15.99337,"twenty":-17.210578,"median":-12.027829,"eighty":-10.630252,"marketCap":4251597622}],"updateTime":1753788317157}}}